The Manufacturers Life Insurance Company Grows Stake in Option Care Health, Inc. (NASDAQ:OPCH)

The Manufacturers Life Insurance Company raised its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 16.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,759,061 shares of the company’s stock after acquiring an additional 244,876 shares during the period. The Manufacturers Life Insurance Company owned approximately 1.01% of Option Care Health worth $48,726,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Option Care Health by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock worth $661,207,000 after acquiring an additional 306,853 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Option Care Health by 157.1% during the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock valued at $250,841,000 after buying an additional 4,549,164 shares during the last quarter. Thrivent Financial for Lutherans boosted its position in shares of Option Care Health by 9.1% during the second quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock valued at $151,218,000 after buying an additional 455,310 shares during the last quarter. Westfield Capital Management Co. LP boosted its position in shares of Option Care Health by 15.4% during the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after buying an additional 688,653 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Option Care Health by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after buying an additional 218,844 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on OPCH shares. Barrington Research increased their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. JMP Securities started coverage on Option Care Health in a research report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 price objective on the stock.

Option Care Health Stock Up 0.8 %

OPCH stock opened at $31.42 on Monday. Option Care Health, Inc. has a fifty-two week low of $26.11 and a fifty-two week high of $34.63. The business’s 50-day moving average is $31.29 and its two-hundred day moving average is $30.40. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The company has a market cap of $5.46 billion, a price-to-earnings ratio of 20.67, a P/E/G ratio of 2.42 and a beta of 1.29.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the prior year, the company earned $0.63 earnings per share. Option Care Health’s revenue was up 14.8% on a year-over-year basis. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling at Option Care Health

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.